To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

AAOS 2016: TXA improves clinical and surgical outcomes after foot and ankle surgery

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
March 2016

AAOS 2016: TXA improves clinical and surgical outcomes after foot and ankle surgery

Vol: 5| Issue: 3| Number:59| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Tranexamic Acid Reduces Postoperative Morbidity in Patients Undergoing Foot and Ankle Surgery

Contributing Authors:
NA Abidi A Govan CM Christensen J Gifford

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

100 patients undergoing foot and ankle surgery were randomized to either administration of tranexamic acid (TXA), or a control group without TXA administration. The purpose of this study was to determine whether the use of TXA was associated with reductions in perioperative morbidity in foot and ankle procedures. Findings indicated significantly decreased ecchymosis, edema, erythema, and bleeding ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.